Pan-European data on health-related quality of life (HRQL) in chronic obstructive pulmonary
disease (COPD) are lacking. This cross-sectional epidemiological study evaluated health …

Background: Chronic obstructive pulmonary disease (COPD) is characterised by both an
accelerated decline in lung function and periods of acute deterioration in symptoms termed …

In patients with COPD, an acute worsening of respiratory symptoms is often described as an
exacerbation. Exacerbations are associated with a significant increase in mortality …

Acute exacerbations are a leading cause of worsening COPD in terms of lung function
decline, quality of life, and survival. They also have a relevant economic burden on the …

Background It has been suggested that withdrawal of inhaled corticosteroids (ICS) in COPD
patients on maintenance treatment results in deterioration of symptoms, lung function and …

Study objective To determine the effectiveness of treatment with corticosteroids in patients
with COPD. Methods In this study, we investigated the effect of a 2-year treatment with …

Inhaled corticosteroids (ICS) are important in reducing exacerbation frequency associated
with chronic obstructive pulmonary disease (COPD). However, little is known about the risk …

BACKGROUND: Treatment with an inhaled corticosteroid (ICS) and long-acting
bronchodilator is recommended for severe/very severe chronic obstructive pulmonary …

Introduction A large group of patients with chronic obstructive pulmonary disease (COPD)
are exposed to an overload of oral corticosteroids (OCS) due to repeated exacerbations …

Background Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in
patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of …